Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
New web tool for easy product selection
Friday, November 15, 2024Laboratory products are increasingly being purchased online but expert advice is often lacking The Eppendorf online shop addresses this issue by offering a digital product advisor to help potential customers easily find the optimal solution for their...
Azome Therapeutics Enters into CRADA with National Center for Advancing Translational Sciences to investigate novel inflammasome antagonist to prevent Bronchopulmonary Dysplasia
Thursday, November 14, 2024Azome Therapeutics an earlystage drug development company today announced that it has entered into a Cooperative Research and Development Agreement CRADA with the National Center for Advancing Translational Sciences NCATS to investigate AZM
BioNTech to Acquire Biotheus to Boost Oncology Strategy
Wednesday, November 13, 2024BioNTech SEand Biotheus today announced the signing of a definitive agreement for the acquisition of Biotheus a clinicalstage biotechnology company dedicated to the discovery and development of novel antibodies to address unmet medical needs of patie...
Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
Tuesday, November 12, 2024Lonza a global development and manufacturing partner to the pharmaceutical biotech and nutraceutical markets today announced it will invest in additional bioconjugation capabilities in Visp CH The expansion will add two multipurpose L manufacturing s...
Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
Tuesday, November 12, 2024AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application BLA for accelerated approval in the US for datopotamab deruxtecan DatoDXd for the treatment of adult patients with locally advanced or metastatic epidermal growth facto...
MAbxience and Egis Enter Strategic License Agreement for Biosimilar Candidates in Key Central and Eastern European Markets
Tuesday, November 12, 2024MAbxience a Fresenius Kabi majorityowned group with partial ownership from Insud Pharma and Egis Pharmaceutical PLC today announced a new strategic license agreement for the commercialization of biosimilar candidates across key Central and Eastern Eu...
Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron
Tuesday, November 12, 2024Adragos Pharma a leading Contract Development Manufacturing Organisation CDMO has significantly enhanced its production capabilities with the completion of a new ampoule filling line at its LivronsurDrme site in France
EnteroBiotix Announces Positive Ph1b Clinical Results of EBX-102 in Liver Cirrhosis
Monday, November 11, 2024EnteroBiotix Limited a clinicalstage biotechnology company focussed on developing bestinclass fullspectrum microbiome therapeutics today announced positive results from its Phase b IMPuLCE study evaluating EBX in patients with liver cirrhosis
Aummune Announces Results from Phase 1 Trial of its Novel AM003 Immunotherapy for the Treatment of Solid Tumors
Friday, November 08, 2024Aummune a clinical stage biopharmaceutical company developing a unique class of oligonucleotide drugs to treat solid tumors announced today the completion of a Phase trial of its proprietary investigational product AM a unique individualized immunot...
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
Friday, November 08, 2024Adaptive Biotechnologies Corporation a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease today announced that Palmetto GBA a Medicare Administ...
